Fragile X founder effects and new mutations in Finland

American Journal of Medical Genetics

Volumn 64, Issue 1, 1996, Pages 226-233

  Zhong, Nan ^a   Kajanoja, Eliisa ^b   Smits, Bram ^a   Pietrofesa, James ^a   Curley, Dennis ^a   Wang, Dauwen ^a   Ju, Weina ^a   Nolin, Sally ^a   Dobkin, Carl ^a   Ryynänen, Markku ^b   Brown, W Ted ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Finland; founder effects; fragile X syndrome; FRAXE; microsatellites

Indexed keywords

ARTICLE; CHROMOSOME SATELLITE ASSOCIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FINLAND; FRAGILE X SYNDROME; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC STABILITY; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MUTATION RATE; PRIORITY JOURNAL;

FINLAND; FOUNDER EFFECT; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE FREQUENCY; HAPLOTYPES; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEATS;

EID: 0029996850     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960712)64:1<226::AID-AJMG41>3.0.CO;2-M     Document Type: Article

References (43)

1. Arinami T, Asano M, Kobayashi K, Yanagi H, Hamaguchi H (1993): Data on the CGG repeat at the fragile X site in the non-retarded Japanese population and family suggest the presence of a subgroup of normal alleles predisposing to mutate. Hum Genet 92:431-436.
2. Brown WT, Jenkins EC (1992): The Fragile X syndrome. In Friedmann T (ed): "Molecular Genetic Medicine." New York: Academic Press, Inc. Vol 2, pp 39-66.
3. Brown WT, Houck GE, Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, Henderson J, Sklower-Brooks S, Jenkins EC (1993): Rapid fragile X carrier screening and prenatal diagnosis by a non-radioactive PCR test. JAMA 270:1569-1575.
4. Brown WT, Zhong N, Dobkin C (1996): Positive fragile X microsatellite associations point to a common mechanism of dynamic mutation evolution. Am J Human Genet 58:641-643.
5. Buyle S, Reyniers E, Vits L, De Boulle K, Handig I, Wuyts FLE, Deelen W, Halley DJJ, Oostra BA, Willems PJ (1993): Founder effect in a Belgian-Dutch fragile X population. Hum Genet 92:269-272.
6. De Boulle K, Verkerk AJMH, Reyniers E, Vits L, Hendrickx J, VanRoy B, VanDenBos F, DeGraaff E, Oostra BA, Willems PJ (1993): A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet 3:31-35.
7. De Graaff E, Rouillard P, Willems PJ, Smits APT, Rousseau F, Oostra BA (1995): Hotspot for deletions in the CGG repeat region of FMR1 in fragile X patients. Hum Mol Genet 4:45-49.
8. Eichler EE, Holden JJA, Popoich BW, Reiss AL, Snow K, Thibodeau SN, Richards CS, Ward PA, Nelson DL (1994): Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet 8:88-94.
9. Fu Y, Kohl DPA, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJMH, Holden JJA, Fenwick RG, Warren S, Oostra BA, Nelson DL, Caskey CT (1991): Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67:1047-1058.
10. Gedeon AK, Baker E, Robinson H, Partington MW, Gross B, Manca A, Korn B, Poustka A, Yu S, Sutherland GR, Mulley JC (1992): Fragile X syndrome without CGG amplification has an FMR1 deletion. Nat Genet 1:341-344.
11. Haataja R, Vaisanen M, Li M, Ryynanen M, Leisti J (1994): The fragile X syndrome in Finland: Demonstration of a founder effect by analysis of microsatellite haplotypes. Hum Genet 94:479-483.
12. Hästbacka J, De la Chapelle A, Sistonen P, Weaver A, Lander E (1992): Linkage disequilibrium mapping in isolated founder populations: Diastrophic dysplasia in Finland. Nat Genet 2:204-211.
13. Hirst MC, Knight SJL, Christodoulou Z, Grewal PK, Fryns JP, Davis KE (1993): Origins of the fragile X syndrome mutation. J Med Genet 30:647-650.
14. Hirst MC, Grewal PK, Davis KE (1994): Precursor arrays for triplet repeat expansion at the fragile X locus. Hum Mol Genet 3:1553-1560.
15. Hirst M, Grewal P, Flannery A, Slatter R, Maher E, Barton D, Fryns J-P, Davis K (1995): Two new cases of FMR1 deletion associated with mental impairment. Am J Hum Genet 56:67-74.
16. Ikonen E, Ignatius J, Norio R, Palo J, Peltonen L (1992): Huntington disease in Finland: A molecular and genealogical study. Hum Genet 89:275-280.
17. Kere J, Norio R, Savilahti E, Estivill X, De la Chaelle A (1989): Cystic fibrosis in Finland: A molecular and genealogical study. Hum Genet 83:20-25.
18. Knight SJL, Flannery AV, Hirst MC, Campbell L, Christodoulou Z, Phelps SR, Pointon J, Middleton-Price HR, Barnicoat A, Pembrey ME, Holland J, Oostra BA, Bobrow M, Davis KE (1993): Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74:127-134.
19. Kunst CB and Warren S (1994): Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell 77:853-861.
20. Macpherson JN, Bullman H, Youings SA, Jacobs PA (1994): Insert size and flanking haplotype in fragile X and normal populations: Possible multiple origins for the fragile X mutation. Hum Mol Genet 3:399-405.
21. Malmgren H, Gustavson K, Oudet C, Holmgren G, Petterson U, Dahl N (1994): Strong founder effect for the fragile X syndrome in Sweden. Eur J Hum Genet 2:103-109.
22. Meijer H, De De Grave E, Merckx DM, Jongbloed RJE, De Die-Smulders CEM, Engelen JJM, Fryns J-P, Curfs PMG, Oostra BA (1994): A deletion of 1.6 Kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. Hum Mol Genet 3:615-620.
23. Norio R, Nevanlinna HR, Perheentupa J (1973): Hereditary diseases in Finland. Ann Clin Res. 5:109-141.
24. Oudet C, Mornet E, Serre JL, Thomas F, Lentes-Zengerling S, Kretz C, Deluchat C, Tejada I, Boue J, Boue A, Mandel JL (1993a): Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes. Am J Hum Genet 52:297-304.
25. Oudet C, Koskull H, Nordstrom AM, Peipo M, Mandel JL (1993b): Striking founder effect for the fragile X syndrome in Finland. Eur J Hum Genet 1:181-189.
26. Pieretti M, Zhang F, Fu Y, Warren ST, Oostra BA, Caskey CT, Nelson DL (1991): Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822.
27. Richards RI, Southerland GR (1992a): Dynamic mutations: A new class of mutations causing human disease. Cell 70:709-712.
28. Richards RI, Holman K, Friend K, Kremer E, Hillen D, Staples A, Brown WT, Goonewardena P, Tarleton J, Schwartz C, Sutherland GR (1992b): Evidence of founder effect for the fragile X syndrome. Nat Genet 1:257-260.
29. Richards RI, Kondo I, Holman K, Yamauchi AI, Seki N, Kishi K, Staples A, Sutherland G, Hori T (1994): Haplotype analysis at the FRAXA locus in the Japanese population. Am J Med Genet 51:412-416.
30. Ryynanen M, Kirkinen P, Mannermaa A, Saarikoski S (1995): Carrier diagnosis of the fragile X syndrome: A challenge in antenatal clinics. Am J Obst Gyn 172:1236-1239.
31. Smits APT, Dreesen J, Post J, Smeets D, De Die-Smulders C, Der Bijl T, Govaerts L, Warren S, Oostra B, Oost B (1993): The fragile X syndrome: No evidence for any recent mutations. J Med Genet 30:94-96.
32. Snow K, Doud LK, Hagerman R, Pergolizzi RG, Erster SH, Thibodeau SN (1993): Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 53:1217-1228.
33. Snow K, Tester DJ, Kruckeberg KE, Schaid DJ, Thibodeau SN (1994): Sequence analysis of the fragile X trinucleotide repeat: Implications of the origin of the fragile X mutation. Hum Mol Genet 3:1543-1551.
34. Trottier Y, Imbert G, Poustka A, Fryns J, Mandel J (1994): Male with typical fragile X phenotype is deleted for the FMR-1 gene and for about 100 Kb of upstream region. Am J Med Genet 51: 454-457.
35. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu YH, Kohl DPA, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, van Ommen GJB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST (1991): Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
36. Wöhrle D, Kotzot D, Hirst MC, Manca A, Korn B, Schmidt A, Barbi G, Rott H-D, Poustka A, Davis KE, Steinbach P (1992): A microdeletion of less than 250 Kb, including the proximal part of the FMR-1 gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am J Hum Genet 51:299-306.
37. Zhong N, Dobkin C, Brown WT (1993): A complex mutable polymorphism located within the fragile X gene, Nat Genet 5: 248-253.
38. Zhong N, Ye LL, Dobkin C, Brown WT (1994a): Fragile X founder chromosome effects: Linkage disequilibrium or microsatellite heterogeneity? Am J Med Genet 51:400-411.
39. Zhong N, Liu X, Gou S, Houck GE, Li S, Dobkin C, Brown WT (1994b): Distribution of FMR1 and associated microsatellite alleles in a normal Chinese population. Am J Med Genet 51:417-422.
40. Zhong N, Dobkin C, Brown WT (1994c): FRAXAC2 instability. Nat Genet 7:122-123.
41. Zhong N, Yang WH, Dobkin C, Brown WT (1995): Fragile X gene instability: Anchoring AGGs and linked microsatellites. Am J Hum Genet 57:351-361.
42. Zhong N, Ju W, Curley D, Wang D, Pietrofesa J, Wu G, Shen Y, Pang C, Poon P, Liu X Gou S, Kajanoaj E, Ryyännen M, Dobkin C, Brown WT (1996a): A Survey of FRAXE Allele Sizes in Three Populations. Am J Med Genet 64:415-419.
43. Zhong N, Ju W, Pietrofesa J, Wang D, Dobkin C, Brown WT (1996b): Fragile X "Gray Zone" Alleles: AGG Patterns, Expansion Risks and Associated Haplotypes. Am J Med Genet 64:261-265.